[1]
Song LL, Li YM. Current noninvasive tests for colorectal cancer screening: An overview of colorectal cancer screening tests. World journal of gastrointestinal oncology. 2016 Nov 15:8(11):793-800
[PubMed PMID: 27895817]
Level 3 (low-level) evidence
[2]
Schreuders EH, Ruco A, Rabeneck L, Schoen RE, Sung JJ, Young GP, Kuipers EJ. Colorectal cancer screening: a global overview of existing programmes. Gut. 2015 Oct:64(10):1637-49. doi: 10.1136/gutjnl-2014-309086. Epub 2015 Jun 3
[PubMed PMID: 26041752]
Level 3 (low-level) evidence
[3]
Medical Advisory Secretariat. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis. Ontario health technology assessment series. 2009:9(10):1-40
[PubMed PMID: 23074514]
[4]
Khakimov N, Khasanova G, Ershova K, Gibadullina L, Vetkina T, Lobisheva G, Chumakova A. Screening for colon cancer: A test for occult blood. The International journal of risk & safety in medicine. 2015:27 Suppl 1():S110-1. doi: 10.3233/JRS-150712. Epub
[PubMed PMID: 26639687]
[5]
Li JN, Yuan SY. Fecal occult blood test in colorectal cancer screening. Journal of digestive diseases. 2019 Feb:20(2):62-64. doi: 10.1111/1751-2980.12712. Epub 2019 Mar 5
[PubMed PMID: 30714325]
[6]
Wielandt AM, Hurtado C, Moreno M, Zárate A, López-Köstner F. [Fecal occult blood test for colorectal cancer screening]. Revista medica de Chile. 2021 Apr:149(4):580-590. doi: 10.4067/s0034-98872021000400580. Epub
[PubMed PMID: 34479346]
[7]
Thomas WM, Pye G, Hardcastle JD, Mangham CM. Faecal occult blood screening for colorectal neoplasia: a randomized trial of three days or six days of tests. The British journal of surgery. 1990 Mar:77(3):277-9
[PubMed PMID: 2322789]
Level 1 (high-level) evidence
[8]
Elsafi SH, Alqahtani NI, Zakary NY, Al Zahrani EM. The sensitivity, specificity, predictive values, and likelihood ratios of fecal occult blood test for the detection of colorectal cancer in hospital settings. Clinical and experimental gastroenterology. 2015:8():279-84. doi: 10.2147/CEG.S86419. Epub 2015 Sep 9
[PubMed PMID: 26392783]
[9]
Sokoro A, Singh H. Fecal Occult Blood Test for Evaluation of Symptoms or for Diagnostic Testing. The American journal of gastroenterology. 2020 May:115(5):679-680. doi: 10.14309/ajg.0000000000000560. Epub
[PubMed PMID: 32058343]
[10]
Young GP, Sinatra MA, St John DJ. Influence of delay in stool sampling on fecal occult blood test sensitivity. Clinical chemistry. 1996 Jul:42(7):1107-8
[PubMed PMID: 8674197]
[11]
Navarro M, Nicolas A, Ferrandez A, Lanas A. Colorectal cancer population screening programs worldwide in 2016: An update. World journal of gastroenterology. 2017 May 28:23(20):3632-3642. doi: 10.3748/wjg.v23.i20.3632. Epub
[PubMed PMID: 28611516]
[13]
Lee MW, Pourmorady JS, Laine L. Use of Fecal Occult Blood Testing as a Diagnostic Tool for Clinical Indications: A Systematic Review and Meta-Analysis. The American journal of gastroenterology. 2020 May:115(5):662-670. doi: 10.14309/ajg.0000000000000495. Epub
[PubMed PMID: 31972617]
Level 1 (high-level) evidence
[14]
Shaukat A, Church TR, Mandel JS. Guaiac Fecal Occult Blood Test and Reduction in Colorectal Cancer Incidence. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2021 Oct:19(10):2217. doi: 10.1016/j.cgh.2021.05.008. Epub 2021 May 6
[PubMed PMID: 33965576]
[15]
Park DI, Ryu S, Kim YH, Lee SH, Lee CK, Eun CS, Han DS. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. The American journal of gastroenterology. 2010 Sep:105(9):2017-25. doi: 10.1038/ajg.2010.179. Epub 2010 May 25
[PubMed PMID: 20502450]
[16]
Greenwald B. From guaiac to immune fecal occult blood tests: the emergence of technology in colorectal cancer screening. Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates. 2005 Mar-Apr:28(2):90-6
[PubMed PMID: 15832108]
[17]
Wilkins T, McMechan D, Talukder A. Colorectal Cancer Screening and Prevention. American family physician. 2018 May 15:97(10):658-665
[PubMed PMID: 29763272]
[18]
Yuan SY, Wu W, Fu J, Lang YX, Li JC, Guo Y, Wang YN, Qian JM, Li JN. Quantitative immunochemical fecal occult blood test for neoplasia in colon cancer screening. Journal of digestive diseases. 2019 Feb:20(2):78-82. doi: 10.1111/1751-2980.12711. Epub 2019 Mar 10
[PubMed PMID: 30714346]
Level 2 (mid-level) evidence
[19]
Ou CH, Kuo FC, Hsu WH, Lu CY, Yu FJ, Kuo CH, Wang JY, Wu MT, Shiea J, Wu DC, Hu HM. Comparison of the performance of guaiac-based and two immunochemical fecal occult blood tests for identifying advanced colorectal neoplasia in Taiwan. Journal of digestive diseases. 2013 Sep:14(9):474-83. doi: 10.1111/1751-2980.12077. Epub
[PubMed PMID: 23701988]
[20]
Quintero E. [Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?]. Gastroenterologia y hepatologia. 2009 Oct:32(8):565-76. doi: 10.1016/j.gastrohep.2009.01.179. Epub 2009 Jul 3
[PubMed PMID: 19577340]
[21]
Vilkin A, Rozen P, Levi Z, Waked A, Maoz E, Birkenfeld S, Niv Y. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test. The American journal of gastroenterology. 2005 Nov:100(11):2519-25
[PubMed PMID: 16279909]
[22]
Kościelniak-Merak B, Radosavljević B, Zając A, Tomasik PJ. Faecal Occult Blood Point-of-Care Tests. Journal of gastrointestinal cancer. 2018 Dec:49(4):402-405. doi: 10.1007/s12029-018-0169-1. Epub
[PubMed PMID: 30232694]
[23]
Rabeneck L, Rumble RB, Thompson F, Mills M, Oleschuk C, Whibley A, Messersmith H, Lewis N. Fecal immunochemical tests compared with guaiac fecal occult blood tests for population-based colorectal cancer screening. Canadian journal of gastroenterology = Journal canadien de gastroenterologie. 2012 Mar:26(3):131-47
[PubMed PMID: 22408764]
[24]
Young GP, Cole SR. Which fecal occult blood test is best to screen for colorectal cancer? Nature clinical practice. Gastroenterology & hepatology. 2009 Mar:6(3):140-1. doi: 10.1038/ncpgasthep1358. Epub 2009 Jan 27
[PubMed PMID: 19174764]
[25]
Ahlquist DA, McGill DB, Schwartz S, Taylor WF, Owen RA. Fecal blood levels in health and disease. A study using HemoQuant. The New England journal of medicine. 1985 May 30:312(22):1422-8
[PubMed PMID: 3873009]
[26]
St John DJ, Young GP, Alexeyeff MA, Deacon MC, Cuthbertson AM, Macrae FA, Penfold JC. Evaluation of new occult blood tests for detection of colorectal neoplasia. Gastroenterology. 1993 Jun:104(6):1661-8
[PubMed PMID: 8500724]
[27]
Wu CI, Tsai CC, Lu CC, Wu PC, Wu DC, Lin SY, Shiea J. Diagnosis of occult blood in human feces using matrix-assisted laser desorption ionization/time-of-flight mass spectrometry. Clinica chimica acta; international journal of clinical chemistry. 2007 Sep:384(1-2):86-92
[PubMed PMID: 17662705]
[28]
Lin SY, Shih SH, Wu DC, Lee YC, Wu CI, Lo LH, Shiea J. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for the detection of hemoglobins as the protein biomarkers for fecal occult blood. Rapid communications in mass spectrometry : RCM. 2007:21(20):3311-6
[PubMed PMID: 17879387]
[29]
Simon JB. Fecal occult blood testing: clinical value and limitations. The Gastroenterologist. 1998 Mar:6(1):66-78
[PubMed PMID: 9531118]
[30]
Fu Y, Wang L, Xie C, Zou K, Tu L, Yan W, Hou X. Comparison of non-invasive biomarkers faecal BAFF, calprotectin and FOBT in discriminating IBS from IBD and evaluation of intestinal inflammation. Scientific reports. 2017 Jun 1:7(1):2669. doi: 10.1038/s41598-017-02835-5. Epub 2017 Jun 1
[PubMed PMID: 28572616]
[31]
Dalle I, Geboes K. Vascular lesions of the gastrointestinal tract. Acta gastro-enterologica Belgica. 2002 Oct-Dec:65(4):213-9
[PubMed PMID: 12619428]
[32]
Papaconstantinou HT, Thomas JS. Bacterial colitis. Clinics in colon and rectal surgery. 2007 Feb:20(1):18-27. doi: 10.1055/s-2007-970196. Epub
[PubMed PMID: 20011357]
[33]
Moralidis E, Papanastassiou E, Arsos G, Chilidis I, Gerasimou G, Gotzamani-Psarrakou A. A single measurement with (51)Cr-tagged red cells or (125)I-labeled human serum albumin in the prediction of fractional and whole blood volumes: an assessment of the limitations. Physiological measurement. 2009 Jul:30(7):559-71. doi: 10.1088/0967-3334/30/7/003. Epub 2009 May 21
[PubMed PMID: 19458409]
[34]
Pineda AA, Dharkar DD, Wahner HW. Clinical evaluation of a 51Cr-labeled red blood cell survival test for in vivo blood compatibility testing. Mayo Clinic proceedings. 1984 Jan:59(1):25-30
[PubMed PMID: 6694429]
[35]
Macrae FA, St John DJ, Caligiore P, Taylor LS, Legge JW. Optimal dietary conditions for hemoccult testing. Gastroenterology. 1982 May:82(5 Pt 1):899-903
[PubMed PMID: 7060911]
[36]
St John DJ, Young GP, McHutchison JG, Deacon MC, Alexeyeff MA. Comparison of the specificity and sensitivity of Hemoccult and HemoQuant in screening for colorectal neoplasia. Annals of internal medicine. 1992 Sep 1:117(5):376-82
[PubMed PMID: 1503328]
[37]
Rosenfield RE, Kochwa S, Kaczera Z, Maimon J. Nonuniform distribution of occult blood in feces. American journal of clinical pathology. 1979 Feb:71(2):204-9
[PubMed PMID: 106720]
[38]
Lynch NM, McHutchison JG, Young GP, Deacon M, St John DJ, Barraclough D. Gastrointestinal blood loss from a new buffered aspirin (Ostoprin): measurement by radiochromium and Hemoquant techniques. Australian and New Zealand journal of medicine. 1989 Apr:19(2):89-96
[PubMed PMID: 2788406]
[39]
Chowdhury ATMD, Longcroft-Wheaton G, Davis A, Massey D, Goggin P. Role of faecal occult bloods in the diagnosis of iron deficiency anaemia. Frontline gastroenterology. 2014 Oct:5(4):231-236. doi: 10.1136/flgastro-2013-100425. Epub 2014 Jan 27
[PubMed PMID: 28839778]
[40]
Harewood GC, McConnell JP, Harrington JJ, Mahoney DW, Ahlquist DA. Detection of occult upper gastrointestinal tract bleeding: performance differences in fecal occult blood tests. Mayo Clinic proceedings. 2002 Jan:77(1):23-8
[PubMed PMID: 11794453]
[41]
Wong C, Dubé C. More on fecal occult blood test misuse. Canadian journal of gastroenterology & hepatology. 2014 Sep:28(8):419-20
[PubMed PMID: 25229464]
[42]
Konrad G, Katz A. Are medication restrictions before FOBT necessary?: practical advice based on a systematic review of the literature. Canadian family physician Medecin de famille canadien. 2012 Sep:58(9):939-48
[PubMed PMID: 22972722]
Level 1 (high-level) evidence
[43]
Narula N, Ulic D, Al-Dabbagh R, Ibrahim A, Mansour M, Balion C, Marshall JK. Fecal occult blood testing as a diagnostic test in symptomatic patients is not useful: a retrospective chart review. Canadian journal of gastroenterology & hepatology. 2014 Sep:28(8):421-6
[PubMed PMID: 25014182]
Level 2 (mid-level) evidence
[44]
Caligiore P, Macrae FA, St John DJ, Rayner LJ, Legge JW. Peroxidase levels in food: relevance to colorectal cancer screening. The American journal of clinical nutrition. 1982 Jun:35(6):1487-9
[PubMed PMID: 7081130]
[45]
Griffith CD, Turner DJ, Saunders JH. False-negative results of Hemoccult test in colorectal cancer. British medical journal (Clinical research ed.). 1981 Aug 15:283(6289):472
[PubMed PMID: 6790022]
[46]
Meyer GW, Komadina K, Perucca P. Vegetable peroxidase is denatured by gastric acid: fresh vegetables do not cause false-positive stool Hemoccults in normal subjects. Gastroenterology. 1991 Sep:101(3):871
[PubMed PMID: 1650322]
[47]
Zwillenberg LO. [Prevention of false results in tests for occult blood in feces]. Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis. 1990 Apr 24:79(17):521-3
[PubMed PMID: 2187220]
[48]
Sinatra MA, St John DJ, Young GP. Interference of plant peroxidases with guaiac-based fecal occult blood tests is avoidable. Clinical chemistry. 1999 Jan:45(1):123-6
[PubMed PMID: 9895348]
[49]
Feinberg EJ, Steinberg WM, Banks BL, Henry JP. How long to abstain from eating red meat before fecal occult blood tests. Annals of internal medicine. 1990 Sep 1:113(5):403-4
[PubMed PMID: 2200323]
[50]
Norfleet RG. Effect of diet on fecal occult blood testing in patients with colorectal polyps. Digestive diseases and sciences. 1986 May:31(5):498-501
[PubMed PMID: 3009111]
[51]
Pignone M, Campbell MK, Carr C, Phillips C. Meta-analysis of dietary restriction during fecal occult blood testing. Effective clinical practice : ECP. 2001 Jul-Aug:4(4):150-6
[PubMed PMID: 11525101]
Level 1 (high-level) evidence
[52]
Jaffe RM, Kasten B, Young DS, MacLowry JD. False-negative stool occult blood tests caused by ingestion of ascorbic acid (vitamin C). Annals of internal medicine. 1975 Dec:83(6):824-6
[PubMed PMID: 1200528]
[53]
Garrick DP, Close JR, McMurray W. Detection of occult blood in faeces. Lancet (London, England). 1977 Oct 15:2(8042):820-1
[PubMed PMID: 71626]
[54]
Franke AA, Cooney RV, Henning SM, Custer LJ. Bioavailability and antioxidant effects of orange juice components in humans. Journal of agricultural and food chemistry. 2005 Jun 29:53(13):5170-8
[PubMed PMID: 15969493]
[55]
Blebea J, McPherson RA. False-positive guaiac testing with iodine. Archives of pathology & laboratory medicine. 1985 May:109(5):437-40
[PubMed PMID: 3838658]
[56]
Hait WN, Snepar R, Rothmen C. False-positive hematest due to povidone-iodine. The New England journal of medicine. 1977 Dec 15:297(24):1350-1
[PubMed PMID: 917095]
[57]
Greenberg PD, Cello JP, Rockey DC. Relationship of low-dose aspirin to GI injury and occult bleeding: a pilot study. Gastrointestinal endoscopy. 1999 Nov:50(5):618-22
[PubMed PMID: 10536315]
Level 3 (low-level) evidence
[58]
Kahi CJ, Imperiale TF. Do aspirin and nonsteroidal anti-inflammatory drugs cause false-positive fecal occult blood test results? A prospective study in a cohort of veterans. The American journal of medicine. 2004 Dec 1:117(11):837-41
[PubMed PMID: 15589487]
[59]
Ahlquist DA, Schwartz S, Isaacson J, Ellefson M. A stool collection device: the first step in occult blood testing. Annals of internal medicine. 1988 Apr:108(4):609-12
[PubMed PMID: 3348567]
[60]
Imafuku Y, Nagai T, Yoshida H. The effect of toilet sanitizers and detergents on immunological occult blood tests. Clinica chimica acta; international journal of clinical chemistry. 1996 Sep 30:253(1-2):51-9
[PubMed PMID: 8879838]
[61]
Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Przeglad gastroenterologiczny. 2019:14(2):89-103. doi: 10.5114/pg.2018.81072. Epub 2019 Jan 6
[PubMed PMID: 31616522]
[62]
Petre-Mandache CB, Margaritescu DN, Mitrut R, Kamal AM, Padureanu V, Cucu MG, Mitrut P. Risk Factors and Genetic Predisposition in Colorectal Cancer: A Study on Young and Old Adults. Current health sciences journal. 2021 Jan-Mar:47(1):84-88. doi: 10.12865/CHSJ.47.01.13. Epub 2021 Mar 31
[PubMed PMID: 34211752]
[63]
US Preventive Services Task Force, Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, Donahue KE, Doubeni CA, Krist AH, Kubik M, Li L, Ogedegbe G, Owens DK, Pbert L, Silverstein M, Stevermer J, Tseng CW, Wong JB. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2021 May 18:325(19):1965-1977. doi: 10.1001/jama.2021.6238. Epub
[PubMed PMID: 34003218]
[64]
Ng K, May FP, Schrag D. US Preventive Services Task Force Recommendations for Colorectal Cancer Screening: Forty-Five Is the New Fifty. JAMA. 2021 May 18:325(19):1943-1945. doi: 10.1001/jama.2021.4133. Epub
[PubMed PMID: 34003238]
[65]
de Kanter C, Dhaliwal S, Hawks M. Colorectal Cancer Screening: Updated Guidelines From the American College of Gastroenterology. American family physician. 2022 Mar 1:105(3):327-329
[PubMed PMID: 35289558]
[66]
Shaukat A, Kahi CJ, Burke CA, Rabeneck L, Sauer BG, Rex DK. ACG Clinical Guidelines: Colorectal Cancer Screening 2021. The American journal of gastroenterology. 2021 Mar 1:116(3):458-479. doi: 10.14309/ajg.0000000000001122. Epub
[PubMed PMID: 33657038]
[67]
Day LW, Bhuket T, Allison J. FIT testing: an overview. Current gastroenterology reports. 2013 Nov:15(11):357. doi: 10.1007/s11894-013-0357-x. Epub
[PubMed PMID: 24218070]
Level 3 (low-level) evidence
[68]
Tinmouth J, Lansdorp-Vogelaar I, Allison JE. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know. Gut. 2015 Aug:64(8):1327-37. doi: 10.1136/gutjnl-2014-308074. Epub 2015 Jun 3
[PubMed PMID: 26041750]